Literature DB >> 26669843

Fibromyalgia Syndrome: Current Considerations in Symptom Management.

Victoria Menzies1.   

Abstract

Fibromyalgia syndrome (FMS), one of the most common rheumatic disorders, is estimated to affect up to 15 million people in the United States, 80% to 90% of whom are women. The syndrome is characterized by the presence of chronic widespread pain and various concurrent symptoms, which may include fatigue, cognitive disturbances (memory problems, difficulty concentrating, confusion), distressed mood (anxiety, depression), nonrestorative sleep, and muscular stiffness. Symptom management appears to be best addressed using a multimodal approach, with treatment strategies tailored to the individual. While medication may provide adequate symptom relief for some patients, experts generally recommend integrating both pharmacologic and nonpharmacologic approaches. Some patients may benefit from the adjunctive use of complementary and alternative medicine (CAM) modalities. Because symptom remission is rare and medication adverse effects can complicate symptom management, well-informed nursing care practices and patient education are essential. This article describes the existing treatment guidelines, discusses pharmacologic and nonpharmacologic approaches (including CAM-based modalities), and outlines nursing approaches aimed at enhancing patient self-management.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26669843     DOI: 10.1097/01.NAJ.0000476162.13177.ae

Source DB:  PubMed          Journal:  Am J Nurs        ISSN: 0002-936X            Impact factor:   2.220


  8 in total

1.  [The AMDS system for the documentation of symptoms and signs associated with pain].

Authors:  Teja W Grömer; Wolfgang Käfferlein; Björn Menger; Ralf Dohrenbusch; Bernd Kappis; Christian Maihöfner; Johannes Kornhuber; Alexandra Philipsen; Helge H O Müller
Journal:  Schmerz       Date:  2017-12       Impact factor: 1.107

2.  The Affective Dimension of Pain Appears to Be Determinant within a Pain-Insomnia-Anxiety Pathological Loop in Fibromyalgia: A Case-Control Study.

Authors:  Lliure-Naima Mory; Daniel de Oliveira Fernandes; Christian Mancini; Michael Mouthon; Joelle Nsimire Chabwine
Journal:  J Clin Med       Date:  2022-06-08       Impact factor: 4.964

3.  Commentary: Mindfulness training for reducing anger, anxiety, and depression in fibromyalgia patients.

Authors:  Lorys Castelli; Valentina Tesio
Journal:  Front Psychol       Date:  2016-05-19

Review 4.  Management of Widespread Pain and Fibromyalgia.

Authors:  Daniel Whibley; Linda E Dean; Neil Basu
Journal:  Curr Treatm Opt Rheumatol       Date:  2016-10-13

5.  Use of Complementary and Integrative Therapies by Fibromyalgia Patients: A 14-Year Follow-up Study.

Authors:  Arya B Mohabbat; Saswati Mahapatra; Sarah M Jenkins; Brent A Bauer; Ann Vincent; Dietlind L Wahner-Roedler
Journal:  Mayo Clin Proc Innov Qual Outcomes       Date:  2019-10-16

Review 6.  The Link between Fibromyalgia Syndrome and Anger: A Systematic Review Revealing Research Gaps.

Authors:  Carmen M Galvez-Sánchez; Gustavo A Reyes Del Paso; Stefan Duschek; Casandra I Montoro
Journal:  J Clin Med       Date:  2022-02-05       Impact factor: 4.241

7.  Explosive Synchronization-Based Brain Modulation Reduces Hypersensitivity in the Brain Network: A Computational Model Study.

Authors:  MinKyung Kim; Richard E Harris; Alexandre F DaSilva; UnCheol Lee
Journal:  Front Comput Neurosci       Date:  2022-03-03       Impact factor: 3.387

Review 8.  Mishel's Model of Uncertainty Describing Categories and Subcategories in Fibromyalgia Patients, a Scoping Review.

Authors:  Ana Fernandez-Araque; Julia Gomez-Castro; Andrea Giaquinta-Aranda; Zoraida Verde; Clara Torres-Ortega
Journal:  Int J Environ Res Public Health       Date:  2020-05-26       Impact factor: 3.390

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.